A study of men diagnosed with prostate cancer in the setting of a community urology practice showed that adherence with active surveillance is good after 3 years of follow-up.
At 10th anniversary meeting, Neal D. Shore, MD, discusses what has made LUGPA “decidedly unique” from other urologic associations.
“Patients have rising expectations for telehealth services as new technology-based ways and preferences for consuming services are shifting into health care. Therefore, it is important for urologists to gear up to meet the market demand,” explains Christian Milaster, MS.
“The results suggest that this compound has rapid efficacy and a favorable safety profile in patients with nocturia due to nocturnal polyuria,” says researcher Diane Newman, DNP.
Cost-effectiveness results favored botulinum toxin at 2 years as well as in an analysis at 5 years accounting for increased cost of the botulinum approach due to repeat injections, according to investigator Heidi S. Harvie, MD, MSCE.
Prostate cancer, BPH, and overactive bladder represent the most spending in the specialty.
Performing green laser enucleation of the prostate with a live audience does not result in more complications, researchers say.
"Proper patient selection, including those with low-/intermediate-risk disease, is paramount," writes Badar M. Mian, MD.
The authors discuss the case of a 57-year-old man who initially presents to a general surgeon with a chief complaint of right lower back and posterior neck pain, with associated soft tissue swelling. On presentation to the authors' institution, he had experienced regrowth of the masses with "ticking" in the right lumbar area that he correlated with his heartbeat. He also reported unintentional weight loss of 15 pounds over the previous 3 months.
The American Association of Clinical Urologists recently celebrated its 50th anniversary with a high-profile annual meeting in Washington, D.C.